Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-04-30 | The current members of the Audit Committee are directors Mr. Patzig, Dr. Luther and Mr. Thompson, the Chairperson of the Audit Committee, all of whom have been determined by the Board to be independent under the NASDAQ listing standards and rules adopted by the SEC applicable to audit committee members. The Board has determined that each of Mr. Patzig, Dr. Luther and Mr. Thompson qualifies as an “audit committee financial expert” under the rules adopted by the SEC and the Sarbanes Oxley Act of 2002. The Audit Committee met eight times during 2014 and did not take any actions by written consent. Director Summary Compensation Table: Michael A. Luther, Ph.D. Fees Earned or Paid in Cash ($) 11,875 Option Awards ($) 19,578 Total ($) 31,453. |
| 2016-04-29 | Michael A. Luther, Ph.D. Dr. Luther has served as President and Chief Executive Officer of Bantam Pharmaceutical, LLC... The current members of the Audit Committee are directors Mr. Patzig, the Chairperson of the Audit Committee, Dr. Luther and Ms. Thomae... The Compensation Committee currently consists of directors Mr. Patzig, the Chairperson of the Compensation Committee, Dr. Luther and Ms. Thomae... Director Summary Compensation Table: Michael A. Luther, Ph.D. Fees Earned or Paid in Cash ($) 34,500 Option Awards ($) 4,595 Total ($) 39,095. |
Data sourced from SEC filings. Last updated: 2026-03-05